Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
28 May 2019 FDA Approves Ruxolitinib for Acute Graft-Versus-Host Disease Haematologic malignancies - Anticancer agents & Biologic therapy
27 May 2019 IMMUNOTARGET Registry in Advanced NSCLC With Oncogenic Driver Alterations Lung and other thoracic tumours - Personalised medicine - Cancer Immunology and Immunotherapy
24 May 2019 Measuring Financial Toxicity After Cancer Diagnosis and Treatment Bioethics, legal and economic issues
23 May 2019 FDA Approves Dalteparin Sodium for Venous Thromboembolism in Paediatric Patients Palliative and supportive care - Cancer in Special Situations / Population
22 May 2019 Deep Learning Model’s Potential to Increase the Accuracy of Lung Cancer Screening Lung and other thoracic tumours - Diagnosis, Imaging and Staging - Epidemiology/Etiology/Cancer Prevention
21 May 2019 Rendering the Tumour Microenvironment More Sensitive to PD-1 Blockade Breast cancer - Cancer Immunology and Immunotherapy
20 May 2019 FDA Approves Venetoclax for CLL and SLL Haematologic malignancies - Anticancer agents & Biologic therapy
17 May 2019 FDA Approves Avelumab Plus Axitinib for Renal Cell Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
16 May 2019 Next Generation Profiling of the Cancer Cell Line Encyclopedia Basic science - Translational research
15 May 2019 How to Improve Access to Expertise in Cancer Imaging Diagnosis, Imaging and Staging
13 May 2019 FDA Approves Ramucirumab for Hepatocellular Carcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
10 May 2019 EMA Recommends Granting a Marketing Authorisation for New Biosimilar Pegfilgrastim Palliative and supportive care
09 May 2019 FDA Approves Ado-trastuzumab Emtansine for Early Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 May 2019 EMA is Updating the Prescribing Information for Lapatinib Breast cancer - Anticancer agents & Biologic therapy
07 May 2019 EMA Recommends Refusal of a Marketing Authorisation for Cabazitaxel Teva Genitourinary cancers - Anticancer agents & Biologic therapy